References
- 1
Angst J.
The emerging epidemiology of hypomania and bipolar II disorder.
J Affect Disord.
1998;
50
143-151
- 2
Angst J, Gamma A, Endrass J. et al .
Obsessive-compulsive syndromes and disorders: significance of comorbidity with bipolar
and anxiety syndromes.
Eur Arch Psy Clin Neurosci.
2005;
255
65-71
- 3
Bloch MH, Landeros-Weisenberger A, Kelmendi B. et al .
A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive
disorder.
Mol Psychiat.
2006;
11
622-632
- 4
Corá-Locatelli G, Greenberg BD, Martin JD. et al .
Valproate monotherapy in an SRI-intolerant patient.
J Clin Psychiat.
1998;
59
82
- 5
Dell’Osso B, Altamura AC, Mundo E. et al .
Diagnosis and treatment of obsessive-compulsive disorder and related disorders.
Int J Clin Pract.
2007;
61
98-104
- 6
Hantouche EG, Angst J, Demonfaucon C. et al .
Cyclothymic OCD: a distinct form?.
J Affect Disord.
2003;
75
1-10
- 7
Hollander E, Dell’Osso B.
Topiramate plus paroxetine in treatment-resistant obsessive-compulsive disorder.
Int Clin Psychopharmacol.
2006;
21
189-191
- 8
Kumar TC, Khanna S.
Lamotrigine augmentation of serotonin re-uptake inhibitors in obsessive-compulsive
disorder.
Aust N Z J Psychiat.
2000;
34
527-528
- 9
Lara DR, Pinto O, Akiskal K. et al .
Toward an integrative model of the spectrum of mood, behavioral and personality disorders
base don fear and anger traits: I. Clinical implications.
J Affect Disord.
2006;
94
67-87
- 10
Lara DR, Akiskal HS.
Toward an integrative model of the spectrum of mood, behavioral and personality disorders
based on fear and anger traits: II. Implications for neurobiology, genetics and psychopharmacological
treatment.
J Affect Disord.
2006;
94
89-103
- 11
Math SB, Janardhan Reddy YC.
Issues in the pharmacological treat-ment of obsessive-compulsive disorder.
Int J Clin Pract.
2007;
61
1188-1197
- 12
Merikangas KR, Akiskal HS, Angst J. et al .
Lifetime and 12-month prevalence of bipolar spectrum in the National Comorbidity Survey
replication.
Arch Gen Psychiat.
2007;
64
544-552
- 13
Sasson Y, Chopra M, Harrari E. et al .
Bipolar comorbidity: from diagnostic dilemmas to therapeutic challenge.
Int J Neuropsychopharmacol.
2003;
6
139-144
- 14
Simon NM, Otto MW, Wisniewski SR. et al .
Anxiety disorder comorbidity in bipolar disorder patients:data from the first 500
participants in the Systematic Treatment Enhancement Program for Bipolar Disorder
(STEP-BD).
Am J Psychiat.
2004;
161
2222-2229
- 15
Swartz CM, Shen WW.
Is episodic obsessive compulsive disorder bipolar? A report of four cases.
J Affect Disord.
1999;
56
61-66
- 16
Zink M, Englisch S, Knopf U. et al .
Augmentation of clozapine with valproic acid for clozapine-induced obsessive-compulsive
symptoms.
Pharmacopsychiatry.
2007;
40
1-2
- 17
Zutshi A, Kamath P, Reddy YC.
Bipolar and nonbipolar obsessive-compulsive disorder: a clinical exploration.
Compr Psychiat.
2007;
48
245-251
L. W. Bisol
Departamento de Bioquímica
ICBS–UFRGS
Av. Iguaçu, 451/201
Porto Alegre – RS
90470-430 Brazil
Phone: +55/51/333 097 32
Fax: +55/51/333 097 32
Email: lwbisol@gmail.com
